TCRT April 2008No. 2 (p 91-154) April 2008 ISSN 1533-0338
High Energy Shock Wave High Energy Shock Waves (HESW) Increase Paclitaxel Efficacy in a Syngeneic Model of Breast Cancer (p. 117-124)The combined effect of high energy shock waves (HESW), generated by a piezoelectric device, and paclitaxel on Mat B-III rat breast cancer cells in vitro and in an in vivo animal model is presented. A significant reduction of in vitro Mat B-III cell proliferation versus cells treated with paclitaxel alone was observed with the combined exposure to paclitaxel (0.1, 1, or 10 nM) and HESW (0.22 mJ/mm2, 1000 shots). Moreover earlier induction and enhanced apoptosis occurred in cells subjected to the combined treatment with paclitaxel and HESW at 1 and 10 nM versus paclitaxel alone (p<0.01 and p<0.001, respectively).
The percentage of apoptotic cells along with BAD mRNA expression, confirm a significant enhancement of apoptosis in tumor tissues subjected to the combined treatment with paclitaxel (2.5 mg/kg on days 7 and 11) and HESW (0.50 mJ/mm2, 500 shots on day 11) in comparison with paclitaxel alone. In conclusion, these data suggest that HESW enhance paclitaxel cytotoxicity in the Mat B-III syngeneic model of breast cancer. Key words: High energy shock waves (HESW); Paclitaxel; Breast cancer; Fisher 344 rats; and Mat B-III cells. Roberto Canaparo, Ph.D.1,2 1Department of Clinical Pathophysiology Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. |
|
Member Login | Home | Editorial Board | Instructions | Subscribe | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
|